Qiagen calls shareholder meeting. Qiagen stock gains 1.50 percent

Published on 10/06/2026 at 10:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Qiagen posted USD 535.04 million revenue, above USD 527.50 million estimates. Qiagen stock costs EUR 41.37 on October 6, 2026 after EUR 40.76.

Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht — Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

Qiagen (ISIN NL0015002SN0) called an extraordinary general meeting for November 6, 2026, and Qiagen stock was up 1.50 percent at EUR 41.37 at Lang & Schwarz on October 6, 2026 at 10:18 a.m. CEST. MarketScreener reported on September 18, 2026 that shareholders will vote on Jonathan M. Pratt joining the managing board after he became chief executive officer on September 1, 2026.

Shareholder vote sets November date

The meeting agenda also includes a vote on the discharge of former chief executive Thierry Bernard. The proposal gives investors a concrete governance checkpoint before Qiagen enters the next phase of its management transition.

The meeting is scheduled for November 6, 2026, at 2:00 p.m. CET in Venlo, the Netherlands, according to MarketScreener. For investors, the date matters because the appointment remains subject to shareholder approval.

Second-quarter figures beat estimates

Qiagen reported USD 535.04 million in revenue for the second quarter of 2026, compared with the USD 527.50 million estimate, while adjusted diluted EPS reached USD 0.62 against USD 0.60 expected, according to MarketBeat on September 25, 2026.

The earnings call also showed the quality of the quarter: Sample Technologies grew 9.00 percent at constant exchange rates, while QIAcuity delivered double-digit growth. Qiagen reaffirmed adjusted diluted EPS of at least USD 2.43 for fiscal 2026, according to the Yahoo Finance transcript dated August 6, 2026.

Stock remains below its yearly high

Qiagen's primary listing is on the NYSE under ticker QGEN, while the October 5, 2026 market capitalization was USD 9.4 billion. The same market snapshot showed a 52-week range of USD 32.53 to USD 57.82, placing the stock below its yearly high in its primary-market currency.

At Lang & Schwarz, Qiagen stock was trading at EUR 41.37 on October 6, 2026 at 10:18 a.m. CEST, up 1.50 percent versus the prior close of EUR 40.76 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Qiagen stock.